logo
Plus   Neg
Share
Email

FDA Approves Merck's SNDAs For PIFELTRO And DELSTRIGO - Quick Facts

Merck (MRK), known as MSD outside the U.S. and Canada, announced Friday that the U.S. Food and Drug Administration (FDA) approved supplemental New Drug Applications (sNDAs) for PIFELTRO (in combination with other antiretroviral agents) and DELSTRIGO (as a complete regimen) that expand their indications to include adult patients with HIV-1 infection.

These patients are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of treatment failure and no known substitutions associated with resistance to PIFELTRO or the individual components of DELSTRIGO.

The FDA's approval of the sNDAs was based on findings from DRIVE-SHIFT, the Phase 3 randomized, international, multicenter, open-label trial evaluating a switch to DELSTRIGO in virologically suppressed participants (HIV-1 RNA <50 copies/mL) on a baseline regimen for at least six months prior to trial entry with no history of virologic failure.

PIFELTRO (doravirine, 100 mg) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) to be administered in combination with other antiretroviral agents.

DELSTRIGO is a once-daily fixed-dose combination tablet of doravirine (100 mg), lamivudine (3TC, 300 mg) and tenofovir disoproxil fumarate (TDF, 300 mg).

DELSTRIGO and PIFELTRO do not cure HIV-1 infection or AIDS. Both were approved in the U.S. on August 30, 2018 for the treatment of HIV-1 infection in adults with no prior antiretroviral treatment history.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Kylie Cosmetics and Kylie Skin is set for a growth after the cosmetics company launched by Kylie Jenner in 2015 sold a major majority stake to beauty conglomerate Coty for $600 million. Jenner, who has been maintaining the full ownership of the company since its launch, sold 51 percent stake in Kylie... FedEx Corp. Chairman and CEO Fred Smith issued a challenge to the New York Times for publishing a "distorted and factually incorrect" story regarding corporate tax payments by the package delivery giant. The New York Times reported on Sunday that FedEx had made a major push for a reduction in corporate taxes when Donald Trump won the presidential election. A new study showed that foot traffic at Starbucks stores declined after the coffee giant changed to an 'open bathroom' policy. According to the study, store attendance per month at Starbuck stores declined 6.8 percent, relative to nearby restaurants and cafes, after the company made changes to its bathroom policy. In May 2018, Starbucks announced a new bathroom policy.
Follow RTT
>